Nevada Growth vs Vapi Disruption: First Look at the FY27 Volume Story
Welspun Living reports Q1 earnings on August 13 with mixed crosscurrents: Nevada pillow plant now fully operational targeting $60M FY27 revenue, but July floods disrupted the India manufacturing base. Expectations point to mid-teen EBITDA margin hold and mid-to-high single-digit revenue growth as the quarter absorbs temporary production headwinds.
The Setup: Welspun Living steps into Q1 FY27 with offsetting tailwinds and headwinds. On the upside, the Nevada pillow manufacturing plant reached full commercial production on June 16, 2026, and is engineered to contribute ~₹480 Cr (~$60M) in revenue for FY27—a 7% boost to group operations via proximity manufacturing for the North American market. On the downside, heavy rains flooded the Vapi, Gujarat manufacturing facility on July 23, creating a temporary production outage just as the quarter was closing. Street consensus (₹170 target, up from bear ₹115) anticipates double-digit revenue growth for the full year with EBITDA progressing into the mid-to-high teens by year-end, but Q1 will likely miss full-year run-rates given the disruption window.
What to Watch: The Earnings Grid
~₹220–240 Cr
vs ₹230 Cr+ implied by FY27 double-digit guide; Q1 likely 5–8% YoY growth given Vapi outage window
~15–16%
on-plan trajectory; Nevada ramp + India price realization offset by near-term cost of disruption recovery
₹20–25 Cr
modest swing from any one-time disruption cost or recovery accrual; FY26 full-year divisional dynamics post-divestment
Data TBA
key watch: Vapi recovery pace and Nevada ramp contribution in Q1 vs full-year trajectory
A Strong Q1 would see revenue near the ₹240 Cr+ mark (8%+ YoY) with Vapi recovery beginning earlier than feared, Nevada contributing volume without margin dilution, and gross margins holding above 40% despite freight and raw-material headwinds. A Weak Q1 would show revenue at or below ₹215 Cr (essentially flat to down YoY), a margin dip into 14–15% due to unabsorbed overhead post-flood, and guidance commentary that push Q1 margin recovery toward Q2–Q3.
On Track? FY27 Guidance Posture
Management laid out double-digit revenue growth for FY27 with EBITDA in the mid-to-high teens by year-end. To deliver that, the company needs Q2–Q4 to grow at 12–15% on a cumulative basis. Q1's likely 5–8% growth implies the company is still on trajectory for full-year targets, provided Vapi ramps back to normal by early Q2 and Nevada scales smoothly. Watch management guidance updates on recovery timeline and capex completion; any pushout of the Nevada yield curve or Vapi restart cost would chip away at FY27 EBITDA hopes.
What the Street Says
Since Last Quarter: The Filing Scan
1 · Nevada Plant Full Operational (Jun 16, 2026)
Pillow unit commenced full commercial production. Target: $60M revenue in FY27 (₹480 Cr equiv.), adding ~7% to group operations. This is a multi-year capex payoff and signals management confidence in North American demand; watch gross margin on this product vs company average.
2 · Vapi Plant Flood Disruption (Jul 23, 2026)
Heavy rains caused production outage at the Gujarat facility. No quantified production loss yet disclosed as of this preview date; management guidance on recovery timeline will be critical on the earnings call. Key to estimate: how many days of lost output, any customer penalty, and restart capex.
3 · Power Unit Divestment (Jul 24–31, 2026)
Board approved and completed transfer of 51% stake in Welspun Captive Power Generation Limited to promoter group company Welspun Corp at ₹67.65 Cr. This is routine portfolio consolidation; unlikely to impact Q1 P&L materially, but removes a legacy business line from consolidated results going forward.
4 · ₹252 Cr Buyback at ₹175 (May 2026)
Promoters tendered 0.88% of shares; buyback shows management conviction in valuation vs ₹164 current price. No change to ownership structure; promoter stake remains 66.24%. Standard shareholder return.
The Close: Q1 Setup in One Sentence
Welspun Living enters Q1 earnings as a two-story play—Nevada scaling as expected and validating the US capex thesis, but Vapi floods likely soften Q1 topline and margins vs full-year trajectory, so the real test is management's candor on disruption recovery and confidence in double-digit FY27 growth realisability.
Three things to watch on result day: (1) Volume commentary—any quantified impact from Vapi outage and expected recovery timeline; (2) Nevada contribution—revenue, volumes, and gross margin signature in the first full quarter; (3) FY27 guidance—any revision to double-digit growth or mid-to-high-teens EBITDA targets, and capex/cash flow implications of the power-unit divestment.
Informational and educational content only. Not investment advice.